Yao Z M, Blackhart B D, Linton M F, Taylor S M, Young S G, McCarthy B J
Gladstone Foundation Laboratories for Cardiovascular Disease, University of California, San Francisco 94140-0608.
J Biol Chem. 1991 Feb 15;266(5):3300-8.
We examined the relationship between the size of human apolipoprotein (apo) B and the formation and secretion of apoB-containing lipoprotein particles. Stable transformants of the rat hepatoma cell line McA-RH7777 harboring a variety of human apoB cDNA constructs were established, and these produced carboxyl-terminally truncated apoB proteins (apoB18, -B23, -B28, -B31, -B48, and -B53). Immunoblotting of apoB proteins secreted into the culture medium and fractionated by equilibrium density ultracentrifugation revealed that each of the truncated apoB species was secreted from the cells. The peak densities of the apoB-containing particles decreased as the length of the apoB proteins increased. Apolipoproteins B18 and B23 appeared at the bottom of the salt gradient (d = 1.23 g/ml), whereas particles containing apoB28, -B31, -B37, -B48, and -B53 exhibited progressive decreases in density. The density distribution of secreted apolipoproteins was not affected by the expression or secretion of these recombinant apoB species. As determined by nondenaturing gel electrophoresis, apoB28, -B31, -B37, -B48, and -B53 formed their own discrete particles, and there was a direct correlation between the size of the particles and the length of the apoB species. The efficiency and rate of secretion of these truncated forms of apoB were studied by measuring the decrease of immunoprecipitated 35S-labeled apoB proteins in the cells and their accumulation in the medium. Proteins corresponding to apoB28 or larger were rapidly and efficiently secreted, whereas apoB18 and apoB23 were secreted much more slowly. These data imply that the size of these truncated apoB forms governs the lipid content of the apoB-containing lipoproteins formed as well as the kinetics of secretion.
我们研究了人类载脂蛋白(apo)B的大小与含apoB脂蛋白颗粒的形成及分泌之间的关系。构建了多种携带人类apoB cDNA构建体的大鼠肝癌细胞系McA-RH7777稳定转化体,这些转化体产生了羧基末端截短的apoB蛋白(apoB18、-B23、-B28、-B31、-B48和-B53)。对分泌到培养基中并通过平衡密度超速离心分级分离的apoB蛋白进行免疫印迹分析,结果显示每种截短的apoB种类都能从细胞中分泌出来。随着apoB蛋白长度的增加,含apoB颗粒的峰值密度降低。载脂蛋白B18和B23出现在盐梯度的底部(d = 1.23 g/ml),而含有apoB28、-B31、-B37、-B48和-B53的颗粒密度逐渐降低。分泌的载脂蛋白的密度分布不受这些重组apoB种类的表达或分泌的影响。通过非变性凝胶电泳测定,apoB28、-B31、-B37、-B48和-B53形成了各自离散的颗粒,颗粒大小与apoB种类的长度之间存在直接相关性。通过测量细胞中免疫沉淀的35S标记的apoB蛋白的减少及其在培养基中的积累,研究了这些截短形式的apoB的分泌效率和速率。与apoB28或更大的蛋白相对应的蛋白能够快速有效地分泌,而apoB18和apoB23的分泌则要慢得多。这些数据表明,这些截短的apoB形式的大小决定了所形成的含apoB脂蛋白的脂质含量以及分泌动力学。